Researchers in the UAB Department of Pathology have developed a comprehensive breast cancer data analysis platform, MammOnc-DB, to address this issue. The platform is comprised of data from more than ...
Gilead Sciences, Inc. GILD announced positive top-line results from yet another late-stage study on breast cancer drug, Trodelvy (sacituzumab govitecan-hziy). Data from the phase III ASCENT-03 study ...
Hosted on MSN
Disparities in 36 cancers across 185 countries, says secondary analysis of global cancer statistics
Cancer remains a significant public health challenge, with the GLOBOCAN 2020 report estimating a staggering 19.3 million new cancer cases and 10 million cancer-related deaths globally. This burden is ...
Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...
Cases of female breast cancer look set to to rise by 38% worldwide over the next 25 years, while deaths from the disease could increase by 68%, according to an analysis by international scientists.
IRVINE, Calif. & AMSTERDAM--(BUSINESS WIRE)--Agendia®, Inc., today announced that new data from its ongoing FLEX Study will be presented at the upcoming ESMO Breast Cancer 2025 congress taking place ...
Spotlight presentation using Guardant Reveal™ test suggests ctDNA has potential to predict sensitivity to endocrine therapy and long-term outcomes in HR+ breast cancer Guardant and its research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback